• Title of article

    The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells

  • Author/Authors

    Nevo، نويسنده , , Ido and Sagi-Assif، نويسنده , , Orit and Meshel، نويسنده , , Tsipi and Ben-Baruch، نويسنده , , Adit and Jِhrer، نويسنده , , Karin and Greil، نويسنده , , Richard and Trejo، نويسنده , , Leonor E. Leider and Kharenko، نويسنده , , Oleg and Feinmesser، نويسنده , , Meora and Yron، نويسنده , , Ilana and Witz، نويسنده , , Isaac P.، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2009
  • Pages
    13
  • From page
    127
  • To page
    139
  • Abstract
    Transendothelial migration (TEM) of tumor cells is a crucial step in metastasis formation. The prevailing paradigm is that the mechanism underlying TEM of tumor cells is similar to that of leukocytes involving adhesion molecules and chemokines. lkine (CX3CL1) is a unique membrane-bound chemokine that functions also as an adhesion molecule. CX3CL1 can be cleaved to a soluble fragment, capable of attracting fractalkine receptor (CX3CR1)-expressing cells. In the present study, we asked if CX3CR1 is involved in the TEM of neuroblastoma cells. onstrated that biologically functional CX3CR1 is expressed by several neuroblastoma cell lines. Most importantly, CX3CR1-expressing neuroblastoma cells were stimulated by CX3CL1 to transmigrate through human bone-marrow endothelial cells. A dose dependent phosphorylation of ERK1/2 and AKT was induced in CX3CR1-expressing neuroblastoma cells by soluble CX3CL1. ition to CX3CR1, neuroblastoma cells also express the CX3CL1 ligand. Membrane CX3CL1 expression was downregulated and the shedding of soluble CX3CL1 was upregulated by PKC activation. together, the results of this study indicate that CX3CR1 plays a functional role in transmigration of neuroblastoma cells through bone-marrow endothelium. These results led us to hypothesize that the CX3CR1–CX3CL1 axis takes part in bone-marrow metastasis of neuroblastoma.
  • Keywords
    CX3CL1 , Fractalkine , CX3CR1 , Human bone-marrow endothelial cells , Neuroblastoma
  • Journal title
    Cancer Letters
  • Serial Year
    2009
  • Journal title
    Cancer Letters
  • Record number

    1813359